ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000228293.1	Ponatinib	Bladder urothelial carcinoma	0.003513075	Sensitive
ENSG00000228293.1	Ponatinib	Lung squamous cell carcinoma	0.030696969	Resistant